The history of the erectile dysfunction drug presents a challenging picture for those considering investment. While the initial launch generated significant profits, the end of its patent opened the door to cheaper https://enrollbookmarks.com/story21574846/the-copyright-and-the-pharmaceutical-industry-a-risky-investment